Latest Stock Market News

“It is only last year that we found the entry segment coming down a little more sharply than in the past. We believe that is obviously a function of affordability. As far as the demography is concerned, we are a very young nation and we would always have a large percentage of first time buyers and there have been 47-48% first time buyers consistently for the last 20-22 years and that has not changed.”

The main question is what are the implications of high inflation and monetary tightening for stock markets? How should investors respond to this situation?

The pan-European STOXX 600 index was up 1.2% by 0720 GMT, after posting its fifth weekly loss in six weeks as investors fled riskier assets on fears of recession.Banks rose 0.5%, while basic material and industrial stocks were also among the biggest boosts to the STOXX 600.

“Any decision on the restriction imposition on the supply side is going to affect the price. It may see a correction of 4% to 5% in the times to come on the pricing side because there has already been a correction in this quarter. I do not see any correction going beyond that but yes in the time to come, it will become normal.”

The brokerage believes AL is well placed to benefit from the CV cycle recovery theme and we estimate its M&HCV volumes to grow at a CAGR of ~28% in FY22-FY24E, with market share reaching ~31% inFY24E.

​In Q4FY22, Indigo has largely maintained volume market share in paints with low single digit volume growth but improved EBITDA margin by 180bps (likely reduction in ad-spends).

NTPC is planning to add 11GW of capacity by FY24-end. Focus continues on addition of large-scale RE capacity, battery storage, green hydrogen and waste-to-energy projects, although the current environment is favouring further brownfield coal capacity addition (NTPC is in advanced stages of adding further 6GWof thermal capacity).

​Despite non-available RM issues, input-price volatility and supply-chain disruptions, Neogen’s FY22 revenue/EBITDA/PAT grew 45%/35%/42% y/y. We expect 27%/31%/43% CAGRs over FY22-24, driven by high-value added products, sharper focus on its CSM business, ramping up organic chemicals capacity and strong demand for pharma and agro-intermediates.

"The key issue is on the supply side, and that would have bigger impact on market expectations (that India could offset disruptions caused by the Ukraine-Russia conflict)."

A total of 195,400 shares changed hands on the counter till 01:49PM (IST).